Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-05-26 Cravatt Benjamin Director Grant or award · Stock Option (Right to Buy) +7,800 7,800
2021-05-26 Brennan Aoife Director Grant or award +4,700 8,614
2021-05-26 Brennan Aoife Director Grant or award · Stock Option (Right to Buy) +7,800 7,800
2021-05-26 Blaug Suzanne Director Grant or award +4,700 14,048
2021-05-26 Blaug Suzanne Director Grant or award · Stock Option (Right to Buy) +7,800 7,800
2021-03-11 KEARNS THOMAS F JR Director Option exercise +18,000 $3.50 $63K 166,164
2021-03-11 KEARNS THOMAS F JR Director Sale −18,000 $35.02 $630K 148,164
2021-03-11 KEARNS THOMAS F JR Director Option exercise · Stock Option (Right to Buy) −12,000 0
2021-03-11 KEARNS THOMAS F JR Director Option exercise · Stock Option (Right to Buy) −6,000 0
2021-03-08 Kouchakji Elias SVP, Clinical Dev, Drug Safety Shares withheld for taxes −5,221 $33.37 $174K 147,346
2021-03-08 Cotroneo Pat SVP, Finance and CFO Shares withheld for taxes −5,657 $33.37 $189K 282,187
2021-03-08 Chung Christine SVP, China Operations Shares withheld for taxes −5,679 $33.37 $190K 166,597
2021-02-24 Wettig Thane Chief Commercial Officer Grant or award +16,500 47,150
2021-02-24 Wettig Thane Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +32,100 32,100
2021-02-24 Kouchakji Elias SVP, Clinical Dev, Drug Safety Grant or award +20,800 152,567
2021-02-24 Kouchakji Elias SVP, Clinical Dev, Drug Safety Grant or award · Stock Option (Right to Buy) +39,900 39,900
2021-02-24 Cotroneo Pat SVP, Finance and CFO Grant or award +21,700 287,844
2021-02-24 Cotroneo Pat SVP, Finance and CFO Grant or award · Stock Option (Right to Buy) +41,700 41,700
2021-02-24 Chung Christine SVP, China Operations Grant or award +21,700 172,276
2021-02-24 Chung Christine SVP, China Operations Grant or award · Stock Option (Right to Buy) +41,700 41,700

Page 16 of 16 · 320 trades